Allosteric Inhibitors of the NS3 Protease from the Hepatitis C Virus

Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir

(2011) Simone Susser et al.   JOURNAL OF CLINICAL VIROLOGY

Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus

(2011) Ann D Kwong et al.   NATURE BIOTECHNOLOGY

Conformational Stability of Hepatitis C Virus NS3 Protease

(2010) Olga Abian et al.   BIOPHYSICAL JOURNAL

Cytosolic zinc buffering and muffling: Their role in intracellular zinc homeostasis

(2010) Robert A. Colvin et al.   Metallomics

Discovery of Specific Flavodoxin Inhibitors as Potential Therapeutic Agents againstHelicobacter pyloriInfection

(2009) Nunilo Cremades et al.   ACS Chemical Biology

Use of the Fused NS4A Peptide−NS3 Protease Domain To Study the Importance of the Helicase Domain for Protease Inhibitor Binding to Hepatitis C Virus NS3-NS4A

(2009) Diane Thibeault et al.   BIOCHEMISTRY

Thermodynamics of zinc binding to hepatitis C virus NS3 protease: A folding by binding event

(2009) Olga Abian et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria

(2008) Angel L. Pey et al.   JOURNAL OF CLINICAL INVESTIGATION